News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LUCI DAVID P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/24/2023 |
4
| LUCI DAVID P (President and CEO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 130,000 options
@ $3.41, valued at
$443.3k
|
|
| 07/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2021 |
4
| LUCI DAVID P (President and CEO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Bought 5,200 shares
@ $4.8, valued at
$25k
|
|
| 07/06/2021 |
4
| LUCI DAVID P (President and CEO) has filed a Form 4 on Acurx Pharmaceuticals, Inc.|
Txns:
| Granted 350,000 options
@ $6.26, valued at
$2.2M
Granted 500,000 options
@ $6.18, valued at
$3.1M
|
|
| 06/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/22/2018 |
4
| LUCI DAVID P (Director) has filed a Form 4 on AMERI Holdings, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.53, valued at
$229.5k
Granted 15,000 restricted stock units
@ $0 |
|
| 02/14/2018 |
3
| LUCI DAVID P (Director) has filed a Form 3 on AMERI Holdings, Inc. |
| 04/21/2017 |
4
| LUCI DAVID P (Director) has filed a Form 4 on PLx Pharma Inc. |
| 01/21/2016 |
4
| LUCI DAVID P (President, CEO, Secretary) has filed a Form 4 on Dipexium Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options
@ $10.16, valued at
$355.6k
|
|
| 01/29/2015 |
4
| LUCI DAVID P (President, CEO, Secretary) has filed a Form 4 on Dipexium Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options
@ $11.35, valued at
$397.3k
|
|
| 03/19/2014 |
4
| LUCI DAVID P (President, CEO, Secretary) has filed a Form 4 on Dipexium Pharmaceuticals, Inc.|
Txns:
| Bought 2,083 shares
@ $12, valued at
$25k
Granted 298,826 options to buy
@ $13.93, valued at
$4.2M
|
|
| 11/02/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|